Innovation Toronto Innovation Toronto

.

In search of new ideas and approaches . . .

  • About Us
    • Privacy Policy
  • List of Institutions
  • Institution Updates
  • 1MM to 3MM Visitors
    • 2MM to 3MM Visitors
    • 1MM to 2MM Visits
  • 100k to 1MM Visitors
    • 500k to 1MM Visitors
    • 300k to 500k Visitors
    • 200k to 300k Visits
    • 100k to 200k Visits
  • Up to 100k Visitors
    • 50k to 100k Visits
    • 25K to 50K Visits
    • 10k to 25k Visits
    • Under 10k Visits
Menu
  • About Us
    • Privacy Policy
  • List of Institutions
  • Institution Updates
  • 1MM to 3MM Visitors
    • 2MM to 3MM Visitors
    • 1MM to 2MM Visits
  • 100k to 1MM Visitors
    • 500k to 1MM Visitors
    • 300k to 500k Visitors
    • 200k to 300k Visits
    • 100k to 200k Visits
  • Up to 100k Visitors
    • 50k to 100k Visits
    • 25K to 50K Visits
    • 10k to 25k Visits
    • Under 10k Visits
loading...
The Latest
  • A wireless light switch that works without batteries could reduce the cost of wiring a house by up to 50 per cent
  • A less invasive brain-machine interface using ultrasound
  • A new catalyst that quickly, cleanly and completely breaks down fishing nets, carpet and clothing without leaving harmful byproducts behind
  • A detonation-based combustion system that utilizes shock waves for propulsion
  • If subliminal advertising is now completely banned without qualification, why are we leaving room for subliminal conditioning by artificial intelligence?
  • Open University of Catalonia
  • A new form of wave devouring propulsion could power ships and help to cut greenhouse gas emissions in the maritime industry
  • Using a new method of crowdsourced feedback to help train robots could also lead to autonomous learning
  • A revolutionary eco-friendly electrochemical refrigerant compressor: Key to Carbon-Neutral Buildings
  • Major drug production breakthrough: $3 per gram vs $3500 per gram to produce the same drug and more
Home Lou Gehrig’s Disease

Slowing the progression of ALS using CRISPR – in mice

Slowing the progression of ALS using CRISPR - in mice

Read more

Share 0
Tweet
Share
Share

A promising drug treatment could revolutionize the treatment of patients suffering from ALS

A promising drug treatment could revolutionize the treatment of patients suffering from ALS

University of Alberta scientists find a new application for an existing drug, with potential to slow progression of the devastating degenerative disease. A new drug could significantly slow... Read more

Share 0
Tweet
Share
Share

New ALS therapy extends survival and reverses some neuromuscular damage in animals

New ALS therapy extends survival and reverses some neuromuscular damage in animals

Drug extends survival, reverses some neuromuscular damage in animals About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s... Read more

Share 0
Tweet
Share
Share

New Therapy Delays Muscle Atrophy in Lou Gehrig’s Disease Mouse Model

New Therapy Delays Muscle Atrophy in Lou Gehrig’s Disease Mouse Model

Mouse study could provide foundation for future human therapeutics Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a... Read more

Share 0
Tweet
Share
Share

Lou Gehrig’s disease or ALS may have a promising medication

Lou Gehrig’s disease or ALS may have a promising medication

Experiments conducted on worms, zebrafish, mice and, finally, on human subjects in a limited clinical trial conclude that pimozide may be effective in treating what’s known as “L... Read more

Share 0
Tweet
Share
Share

Lou Gehrig’s Disease: From Patient Stem Cells to Potential Treatment Strategy in One Study

Lou Gehrig’s Disease: From Patient Stem Cells to Potential Treatment Strategy in One Study

Translational Research Goes Seamless: After Creating Neurons From Patients’ Skin Cells, Cedars-Sinai-led Researchers ‘Treat’ Gene Defect in a Dish, Indicating the Therapy May Work Although t... Read more

Share 0
Tweet
Share
Share

1960s-Era Anti-Cancer Drug Points to Treatments for Lou Gehrig’s Disease

1960s-Era Anti-Cancer Drug Points to Treatments for Lou Gehrig's Disease

“From this work it appears that cisplatin is a promising lead compound for the rational design of ALS treatments,” A long-used anti-cancer drug could be a starting point to devel... Read more

Share 0
Tweet
Share
Share

Researchers Make Breakthrough in Treating Lou Gehrig’s Disease

Researchers Make Breakthrough in Treating Lou Gehrig’s Disease

UCSD scientists announced last week that a metabolism-boosting protein, PCG-1?, may help restore cell function in individuals afflicted by Lou Gehrig’s Disease. Lou Gehrig’s disease, or Amyo... Read more

Share 0
Tweet
Share
Share

Most Visited Today

Most Visited This Week

Most Visited This Month

Most Visited This Year

Featured Today . . .

A wireless light switch that works without batteries could reduce the cost of wiring a house by up to 50 per cent

Read More
on 03 December 2023

A less invasive brain-machine interface using ultrasound

Read More
on 02 December 2023

A detonation-based combustion system that utilizes shock waves for propulsion

Read More
on 30 November 2023

A new catalyst that quickly, cleanly and completely breaks down fishing nets, carpet and clothing without leaving harmful byproducts behind

Read More
on 01 December 2023
The Latest University & Research Institutions Updated . . .

University of Alberta

Northwestern University

French Institute of Health and Medical Research (INSERM)

University of Alabama in Huntsville (UAH)

Air Force Research Laboratory (AFRL)

Cranfield University

Howard Hughes Medical Institute (HHMI)

Chung-Ang University

California Institute of Technology (Caltech)

Open University of Catalonia

Robert R. McCormick School of Engineering and Applied Science

Massachusetts Institute of Technology (MIT)

load more

Copyright 2023. Created by Innovation Toronto

Desktop Version Mobile Version